UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: February 5, 2021
Accession Number:
Submission Type:
CIK: 0001335105
Company Name: LIXTE BIOTECHNOLOGY HOLDINGS, INC.
File Number: 333-252430